Results of interventional treatment of peripheral slow-flow malformations.
Jens-Christian AltenberndFelix KuttaMichael ForstingJens TheysohnStefan RohdePublished in: CVIR endovascular (2023)
Sclerotherapy is a promising way of treating slow-flow-malformations. Polidocanol has proved to be a save sclerosing agent. The reduction of major symptoms was substantial in most cases and lasted for many years.
Keyphrases